<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON D.C. 20549

                                    FORM 10-Q

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
      SECURITIES EXCHANGE ACT OF 1934

      For the quarterly period ended: September 30, 2003

                                       OR

[ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
      SECURITIES EXCHANGE ACT OF 1934

      For the transition period from ______ to ______.

      Commission File Number: 0-17458

                                WRP CORPORATION
             (Exact name of registrant as specified in its charter)

<TABLE>
<S>                                                <C>
                MARYLAND                               73-1326131
                --------                               ----------
    (State or other jurisdiction of                 (I.R.S. Employer
     incorporation or organization)                Identification No.)
</TABLE>

                         500 PARK BOULEVARD, SUITE 1260
                                ITASCA, IL 60143
                                ----------------
                     (Address of principal executive office)

                                 (630) 285-9191
               (Registrant's telephone number including area code)

      Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days.

                                                Yes [X]    No [ ]

            Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the Exchange Act).

                                                Yes [ ]    No [X]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

      The number of shares of the issuer's Common Stock, par value $.01 per
share, and issuer's Series A Convertible Common Stock, par value $.01 per share,
outstanding as of November 4, 2003, was 5,803,692 and 1,252,538, respectively.
<PAGE>
                                 WRP CORPORATION

                                      INDEX

                         PART I - FINANCIAL INFORMATION

      A quarterly review of the first quarter financial statements has been
performed by an independent certified public accountant in accordance with
Statement of Auditing Standards No. 100.

<TABLE>
<S>                                                                                   <C>
Item 1.

      Condensed Consolidated Balance Sheets
      September 30, 2003 (unaudited) and June 30, 2003, (unaudited)..............     pgs.3-4

      Condensed Consolidated Statements of Operations (unaudited) for the
      Three Months Ended September 30, 2003 and 2002.............................       pg. 5

      Condensed Consolidated Statements of Cash Flow (unaudited) for the
      Three months ended September 30, 2003 and 2002.............................       pg. 6

      Notes to Interim Consolidated Financial Statements (unaudited).............       pg. 7

Item 2.

      Management's Discussion and Analysis of Financial Condition and
      Results of Operations......................................................       pg.17

Item 3.

      Quantitative and Qualitative Disclosures About Market......................       pg.22

Item 4. Controls and Procedures..................................................       pg.22


                           PART II - OTHER INFORMATION

Items 1.-5.......................................................................       pg.23

Item 6...........................................................................       pg.23

</TABLE>


                                       2
<PAGE>
WRP CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 2003 AND JUNE 30, 2003


<TABLE>
<CAPTION>
                           ASSETS                             2003          2003
                                                          ------------  ------------
<S>                                                       <C>           <C>
CURRENT ASSETS
  Cash and cash equivalents                               $    531,921  $    420,949
  Accounts receivable - trade, net of allowance for
    doubtful accounts of  $333,625 at September 30, 2003
    and June 30, 2003                                        2,045,625     2,317,178
  Inventories, net                                           8,662,616     8,796,339
  Prepaid expenses                                             520,891       522,914
  Due from affiliate, net of allowance for doubtful
     accounts of  $5,586,271 at September 30, 2003 and
     June 30, 2003                                           3,701,441     3,320,544
  Deferred tax assets                                               --      (435,293)
  Other receivables                                            953,993     1,382,078
                                                          ------------  ------------

                Total current assets                        16,416,487    16,324,709

PROPERTY, PLANT AND EQUIPMENT
  Land rights and land improvements                            736,535       736,535
  Construction in progress                                     165,675        27,688
  Equipment, furniture and fixtures                         16,934,117    16,767,720
  Building improvements                                      2,337,046     2,336,683
  Vehicles                                                          --       115,467

                Total property, plant and equipment         20,173,373    19,984,093

  Less accumulated depreciation and amortization            11,323,304    10,876,090
                                                          ------------  ------------

                Property, plant and equipment, net           8,850,069     9,108,003

OTHER ASSETS
  Other assets                                                 525,633       531,870
                                                          ------------  ------------

                Total other assets                             525,633       531,870
                                                          ------------  ------------

                                                          $ 25,792,189  $ 25,964,582
                                                          ============  ============
</TABLE>


                                       3
<PAGE>
WRP CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS - CONTINUED
SEPTEMBER 30, 2003 AND JUNE 30, 2003


<TABLE>
<CAPTION>
          LIABILITIES AND SHAREHOLDERS' EQUITY                          2003           2003
                                                                    ------------   ------------
<S>                                                                 <C>            <C>
CURRENT LIABILITIES
  Accounts payable - trade                                          $  1,791,259   $  1,733,300
  Trade notes payable to bank                                          2,786,157      2,959,587
  Notes payable and current portion of long-term
    obligations                                                        1,280,677      1,264,992
  Due to affiliates                                                    3,890,537      3,890,537
  Accrued expenses                                                     2,874,529      2,716,428
                                                                    ------------   ------------

                Total current liabilities                             12,623,159     12,564,844

LONG-TERM DEBT                                                                --          5,163

DEFERRED TAX LIABILITIES                                               1,129,215        645,036

COMMITMENTS AND CONTINGENCIES                                                 --             --

MINORITY INTEREST IN SUBSIDIARY                                        1,390,432      1,483,958

SHAREHOLDERS' EQUITY
  Series A common stock, $.01 par value;
    1,252,538 shares authorized; 1,252,538
    shares issued and outstanding at
    September 30, 2003 and June 30, 2003                                  12,525         12,525
  Common stock, $.01 par value; 10,000,000 shares
    authorized; 5,803,692 shares issued at September 30,
    2003 and June 30, 2003                                                58,037         58,037
  Additional paid-in capital                                          17,942,471     17,942,471
  Accumulated deficit                                                 (5,734,474)    (5,118,276)
                                                                    ------------   ------------
                                                                      12,278,559     12,894,757
  Less common stock in treasury, at cost, 387,800 shares
    at September 30, 2003 and June 30, 2003                            1,629,176      1,629,176
                                                                    ------------   ------------

                Total shareholders' equity                            10,649,383     11,265,581
                                                                    ------------   ------------

                                                                    $ 25,792,189   $ 25,964,582
                                                                    ============   ============
</TABLE>


                                       4
<PAGE>
WRP CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002


<TABLE>
<CAPTION>
                                                                     Three Months Ended
                                                                     ------------------
                                                                     2003           2002
                                                                 ------------   ------------
<S>                                                              <C>            <C>
Net sales                                                        $  9,786,226   $ 10,541,504

Cost of goods sold                                                  8,048,922      8,526,381
                                                                 ------------   ------------

                Gross profit                                        1,737,304      2,015,123

Operating expenses
  Selling, general and administrative                               2,297,740      2,090,328
                                                                 ------------   ------------

Loss from operations                                                 (560,436)       (75,205)

Other Income and Expense
   Interest expense                                                    44,020         48,725
   Other income                                                        29,479        284,149
                                                                 ------------   ------------

                (Loss) income from continuing operations before
                  provision for (benefit from) income taxes
                  and minority interest                              (574,977)       160,219

Provision for (benefit from) income taxes                              50,748         (4,255)
                                                                 ------------   ------------

                (Loss) income from continuing operations before
                  minority interest                                  (625,725)       164,474

Minority interest in (loss) income of subsidiary                       (9,526)        39,052
                                                                 ------------   ------------


                 NET (LOSS) INCOME                               $   (616,199)  $    125,422
                                                                 ============   ============

Basic net (loss) income per common share                         $      (0.09)  $       0.02

Diluted net (loss) income per common share                       $      (0.09)  $       0.02
</TABLE>


                                       5
<PAGE>
WRP CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002


<TABLE>
<CAPTION>
                                                                          Three Months Ended
                                                                          ------------------
                                                                          2003          2002
                                                                      -----------   -----------
<S>                                                                   <C>           <C>
Cash flows from operating activities
  Net (loss) income                                                   $  (616,199)  $   125,422
  Adjustments to reconcile net (loss) income to net cash provided by
    (used in) operating activities
      Depreciation                                                        447,214       477,601
      Deferred income taxes                                                48,886        73,075
      Changes in operating assets and liabilities
        Accounts receivable - trade, net                                  271,553     2,273,278
        Inventories, net                                                  133,723     1,768,467
        Prepaid expenses                                                    2,023       158,953
        Other assets                                                      434,323      (138,134)
        Accounts payable - trade                                           57,959    (2,062,469)
        Accrued expenses                                                  158,101      (144,874)
        Amounts due to and from affiliates                               (380,898)     (177,392)
                                                                      -----------   -----------

                Net cash provided by operating activities                 556,685     2,353,927

Cash flows from investing activities
  Capital expenditures                                                   (189,279)     (145,809)
  Minority interest in subsidiary                                         (93,526)      (44,948)
                                                                      -----------   -----------

                Net cash used in investing activities                    (282,805)     (190,757)

Cash flows from financing activities
  Net payments on trade notes payable to bank                            (173,430)    2,122,734
  Net borrowings (payment) on notes payable                                10,522    (3,918,742)
  Payments for treasury stock repurchases                                      --       (10,800)
                                                                      -----------   -----------

                Net cash used in financing activities                    (162,908)   (1,806,808)
                                                                      -----------   -----------

Net increase in cash and cash equivalents                                 110,972       356,362

Cash and cash equivalents, beginning of period                            420,949       451,948
                                                                      -----------   -----------

Cash and cash equivalents, end of period                              $   531,921   $   808,310
                                                                      ===========   ===========
</TABLE>


                                       6
<PAGE>
WRP CORPORATION
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
SEPTEMBER 30, 2003

1.      DESCRIPTION OF BUSINESS:

        We are a leading marketer of foodservice and medical examination gloves
in the United States through our wholly owned subsidiary, American Health
Products Corporation ("AHPC"). We are also a manufacturer of disposable latex
examination and foodservice gloves through our 70% owned Indonesian
manufacturing facility, PT WRP Buana Multicorpora ("PT Buana"). In 2002, we
broadened our product line to include other disposable items to be used
primarily in the foodservice industry.

2.      BASIS OF PRESENTATION:

        The accompanying unaudited condensed, consolidated financial statements
have been prepared in accordance with generally accepted accounting principles
in the United States of America, for interim financial information and with the
instructions to Form 10-Q. Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting principles
for complete financial statements. In the opinion of management, all adjustments
necessary for a fair presentation, consisting only of normal recurring
adjustments, have been included. For further information, refer to the
consolidated financial statements contained in the Annual Report on Form 10-K
for the year ended June 30, 2003, filed October 14, 2003. The results of
operations for the three-month period ended September 30, 2003, may not be
indicative of the results that may be expected for the fiscal year ended June
30, 2004.

3.      PRINCIPLES OF CONSOLIDATION:

        The accompanying interim consolidated financial statements include our
accounts and those of AHPC and our 70% owned subsidiary, PT Buana. All
significant intercompany transactions have been eliminated in consolidation.

4.      MAJORITY SHAREHOLDER:

        WRP Asia Pacific Sdn. Bhd., a Malaysian corporation ("WRP Asia"), owns
all of our outstanding Series A Common Stock and is our majority shareholder.

        At September 30, 2003, WRP Asia had a 53.2% ownership interest in us.
WRP Asia is one of the world's leading manufacturers of high-quality, disposable
gloves primarily for use by healthcare professionals in the acute care,
alternative care and foodservice markets, and for critical environments in the
electronics industries, scientific laboratories, pharmaceutical industries and
other related industries. AHPC purchases a majority of its powder-free latex
exam gloves from WRP Asia.


                                       7
<PAGE>
5.      COMMON STOCK:

        At September 30, 2003, we had issued 1,252,538 shares of Series A
Convertible Common Stock and 5,803,692 shares of Common Stock for a total of
7,056,230 shares. The terms of the Series A Common Stock owned by WRP Asia are
substantially the same as our Common Stock except:

        a.  Each share of Series A Common Stock is convertible into one share of
            our Common Stock, $.01 par value. We have reserved 1,252,538 shares
            of Common Stock for issuance upon conversion of the Series A Common
            Stock.

        b.  Series A Common Stock entitles WRP Asia to elect all Class A
            directors, who represent a majority of our Board of Directors, and
            to vote with the holders of Common Stock as a single class with
            respect to all other matters subject to a vote of the shareholders.

        During the three months ended, September 30, 2003, we did not sell any
shares of our Common Stock.

6.         FOREIGN CURRENCY TRANSACTIONS:

        Gains and losses from foreign currency exchange transactions are
included in net loss in the period in which they occur. During the quarters
ended September 30, 2003 and 2002, the foreign exchange (loss)/gain included in
the determination of net income was $(7,733) and $7,188, respectively. The
functional currency of PT Buana is the U.S. dollar.

7.         RELATED-PARTY TRANSACTIONS:

        At September 30, 2003 and 2002, amounts due from/to affiliates consist
of the following:
<TABLE>
<CAPTION>
                                2003          2002
                            -----------   -----------
<S>                         <C>           <C>
Due from Affiliate-
Current - WRP Asia          $ 9,287,712   $ 9,023,877

Due to Affiliate-
Current - WRP Asia          $(3,890,537)  $(2,549,443)
                            -----------   -----------

Amounts due from
Affiliate - Net *           $ 5,397,175   $ 6,474,434
                            ===========   ===========

Purchases from Affiliate -  $       (--)  $(1,186,495)
                            ===========   ===========

Sales to Affiliate -        $   117,511   $ 3,017,180
                            ===========   ===========
</TABLE>

*    Right of set-off granted in October 2002.


                                       8
<PAGE>
        The outstanding accounts receivable from WRP Asia results primarily from
sales of product to WRP Asia (powder-free exam gloves produced by PT Buana),
cash advances, charges for obtaining FDA approval of the gloves imported from
WRP Asia and other items. AHPC purchased virtually all of its latex powder-free
exam gloves from WRP Asia in 2002, 2001, 2000 and 1999. Management believes
transactions between operating segments are made at prevailing rates. AHPC
purchases its powdered latex gloves from its 70% subsidiary, PT Buana, as well
as from third-party suppliers other than WRP Asia.

        As of September 30, 2003, we have outstanding accounts receivable from
WRP Asia of approximately $9,287,712. Subsequent to June 30, 2002, the amounts
due to PT Buana of approximately $5,586,000 were assigned to us in partial
satisfaction of intercompany amounts due from PT Buana to us. As of September
30, 2003, there is approximately $345,272 owing PT Buana from WRP Asia.

        As of September 20, 2003, we have accounts payable to WRP Asia of
approximately $3,890,537, primarily resulting from the purchase of inventories
from WRP Asia.

        The net amount due from WRP Asia, before allowance for doubtful accounts
at September 30, 2003, was approximately $9,287,712, against which we have
provided an allowance for doubtful accounts of approximately $5,586,000
(representing all amounts due for the sale of product from PT Buana to WRP Asia
at June 30, 2002) due to the uncertainty of the finalization of WRP Asia's
refinancing plan, which has been ongoing for over 18 months without completion
as of the date of the reserve for doubtful accounts.

        Subsequent to September 30, 2002, we entered into a formal agreement
with WRP Asia, to provide for the full and complete right of offset of any trade
payables due against amounts they owe to us and AHPC. We continue to purchase
gloves from WRP Asia and believe that the unreserved amounts due to WRP Asia
from WRPC and AHPC of approximately $188,825 at September 30, 2003 are
realizable based upon the agreement granting right of offset and ongoing
purchases from WRP Asia. In management's opinion, while we have been advised by
WRP Asia that it does not currently intend to seek protection from creditors,
should such action take place, we would have to reevaluate the ability to offset
payables to WRP Asia against our receivables from them.

        On July 24, 2002, our Board of Directors approved a proposal submitted
by the independent directors to form a Special Evaluation Committee (the
"Committee"). The Committee was comprised of our "B" Directors, Robert J.
Simmons and Don L. Arnwine, as well the independent "A" Directors, G. Jeff
Mennen and Richard J. Swanson. The purpose of the Committee is to examine the
WRP Asia restructuring process, as well as the options and alternatives
available to us. The approval of the stock redemption and exchange agreement has
been unanimously approved by the Committee, and it has obtained a fairness
opinion advising that the transaction is fair to our shareholders.

        Additionally, interest rates in many Asian-Pacific countries have been
heavily dependent upon international trade and are, accordingly, affected by
protective trade barriers and the economic conditions of their trading partner.
The enactment by the government of principal trading partners protectionist
trade legislation, reduction of foreign investment or general


                                       9
<PAGE>
declines in the international securities markets could have a significant
adverse effect upon the economies of the Asian-Pacific countries. The financial
statements do not include any adjustment that might result from these
uncertainties and any related effects will be reported in the financial
statements as they become known and estimable.

8.      NET LOSS PER SHARE:

        We follow the Statement of Financial Accounting Standards No. 128,
"Earnings Per Share (EPS)" ("SFAS 128"), which requires dual presentation of
basic and diluted earnings per share for all periods presented. Basic EPS
amounts are based on the weighted-average number of shares of common stock
outstanding during each period while diluted EPS amounts are based on the
weighted-average number of shares of common stock outstanding during the period
and the effect of dilutive stock options and warrants. The weighted-average
number of common shares and common share equivalents outstanding for the three
months ended September 30, 2003 and 2002 is as follows:

<TABLE>
<CAPTION>
                                                Three Months Ended         Three Months Ended
                                                September 30, 2003         September 30, 2002
                                                ------------------         ------------------
<S>                                             <C>                        <C>
Basic weighted-average number of
Common shares outstanding                           6,632,734                  6,647,802
Dilutive effect of common share
Equivalents                                            11,111                         --
                                                    ---------                  ---------
Dilutive weighted-average number of
common shares outstanding                           6,643,845                  6,647,802
</TABLE>


        At September 30, 2003, there were 7,056,230 shares of our Common Stock
and Series A Common Stock outstanding.

        As approved by the Board of Directors, all outstanding stock options at
February 29, 2000, to current employees, officers and directors were repriced
effective February 29, 2000, to $2.07, the closing price on that date. All of
the stock options, which were repriced, totaling 483,600 options, originally
contained exercise prices that were significantly higher than the market price.
We are subject to variable accounting; however, the share price has not exceeded
$2.07.

9.      ACCOUNTING FOR INCOME TAXES:

        We record income taxes in accordance with Statement of Financial
Accounting Standards No. 109 ("SFAS 109"). SFAS 109 utilizes the liability
method and deferred taxes are determined based on the estimated future tax
effects of differences between the financial statement and tax basis of assets
and liabilities given the provisions of enacted tax laws. Deferred income tax
provisions and benefits are based on the changes in the deferred tax asset or
tax liability from period to period.

        Our U.S. operations had generated net operating loss carry-forwards
("NOL's") in prior years of which approximately $2.3 million is remaining at
September 30, 2003. These NOL's are fully reserved and are included as a
component of deferred tax assets. These NOL's will be available to offset future
U.S. generated taxable income and will begin expiring in 2004. In accordance
with federal tax regulations, usage of the NOL's are and have been subject to


                                       10
<PAGE>
limitations as a direct result of certain ownership changes that have occurred
in the past, and may be further limited should WRP Asia transfer ownership of
its shares of stock to another holder.

        For the three months ended September 30, 2003 and 2002, we have recorded
a provision for (benefit) from income taxes of $50,748 and $(4,255),
respectively.

10.     CONTINGENCIES:

        Over the last several years, numerous product liability lawsuits have
been filed against suppliers and manufacturers of latex gloves alleging, among
other things, adverse allergic reactions. We are one of numerous defendants that
have been named in such lawsuits. During the three months ended September 30,
2003, there were no additional product liability lawsuits filed, and we were
dismissed from seven lawsuits. At September 30, 2003, we were involved in a
total of 32 lawsuits, either as a named defendant, third party or an
indemnifier. None of these lawsuits name us as the sole defendant in these
claims.

        We possess product liability insurance coverage which covers the defense
costs and certain damage awards associated with the product liability claims
against ourselves, AHPC and PT Buana, in addition to the indemnity of AHPC's
customers to the limits of its policy, subject to deductions on each claim, to
be paid by AHPC. We believe that all legal claims are adequately provided for
and if not provided for, are without merit or involve such amounts that would
not materially or adversely affect us. However, there is no assurance that
AHPC's insurance will be sufficient to meet all damages for which we may be held
liable. For example, in a jury trial, even where actual damages are somewhat
limited, or where causation of liability is questionable, the jury may choose to
award a substantial verdict to the plaintiff. Likewise, there is no assurance
that the outcome of these suits will not adversely affect our operations or
financial condition. We will vigorously contest any latex claim initiated
against us, but will enter into a settlement agreement, where, after careful
consideration, management determines that our best interests will be served by
settling the matter. In addition, there can be no assurances that product
liability insurance for these claims will continue to be available to us or, if
available, that it will be available in sufficient amounts and at affordable
terms.

11.     COMPREHENSIVE INCOME:

        Statement of Financial Accounting Standards No. 130, "Reporting
Comprehensive Income" ("SFAS 130"), requires companies to report all changes in
equity during a period, except those resulting from investment by owners and
distributions to owners, in a financial statement for the period in which they
are recognized. Comprehensive profit (loss) for the three months ended September
30, 2003 and 2002 was equal to net profit (loss) and there were no accumulated
other comprehensive income items during those periods.

12.     SEGMENT REPORTING:

        We have two business segments: manufacturing and distribution. These
segments are managed as separate strategic business units due to the distinct
nature of their operations and customer bases. The manufacturing segment, which
represents the operations of PT Buana, manufactures latex gloves and sells them
primarily to AHPC and other customers through WRP Asia's distribution network.
All operations of the manufacturing segment are located in


                                       11
<PAGE>
Indonesia. The distribution segment involves the procurement and sale of gloves
purchased from the manufacturing segment and other glove manufacturers and then
sold to national and regional healthcare, foodservice, retail and other
distributors. The operations of the distribution segment are located entirely
within the U.S.

        We evaluate segment performance based on income (loss) before provision
for (benefit from) income taxes and minority interest ("Pre-tax income (loss)").
Transactions between operating segments are made at prevailing market rates.

        The following tables provide financial data for the three months ended
September 30, 2003 and 2002 for these segments:

<TABLE>
<CAPTION>
THREE MONTHS ENDED
SEPTEMBER 30, 2003                    MANUFACTURING   DISTRIBUTION   ELIMINATIONS   CONSOLIDATED
                                      -------------   ------------   ------------   ------------
<S>                                   <C>             <C>            <C>            <C>
Revenues from external customers        $  3,221,576  $  6,564,650   $         --   $  9,786,226
Revenues from other operating segments     1,580,887            --     (1,580,887)            --

Pre-tax income (loss )                        18,994      (593,971)            --       (574,977)
Total Assets                              11,810,012    13,982,177             --     25,792,189
</TABLE>



<TABLE>
<CAPTION>
THREE MONTHS ENDED
SEPTEMBER 30, 2002                        MANUFACTURING   DISTRIBUTION  ELIMINATIONS      CONSOLIDATED
                                          -------------   ------------  ------------      ------------
<S>                                       <C>            <C>            <C>               <C>
Revenues from external customers            $ 3,351,426  $ 7,190,078    $        --       $10,541,504
Revenues from other operating segments        1,044,074           --     (1,044,074)               --
Pre-tax income                                  119,430       40,789             --           160,216
Total Assets                                 11,581,797   17,375,072             --        28,956,869
</TABLE>

13.        NEW ACCOUNTING STANDARDS AND PRONOUNCEMENTS:

        In June 2002, the FASB issued SFAS No. 146, "Accounting for Costs
Associated with Exit or Disposal Activities." This statement addresses financial
accounting and reporting for costs associated with exit or disposal activities
and nullifies Emerging Issues Task Force (EITF) Issue No. 94-3, "Liability
Recognition for Certain Employee Termination Benefits and Other Costs to Exit
and Disposal Activity (including Certain Costs Incurred in a Restructuring)."
The provisions of this statement are effective for exit and disposal activities
that are initiated after December 31, 2002, with early adoption encouraged. We
have adopted the provision set forth in this statement for all exit and disposal
activities initiated after December 31, 2002.

       In November 2002, the FASB issued FASB Interpretation ("FIN") No. 45,
Guarantor's Accounting and Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Other." This interpretation addresses the
disclosures to be made by a guarantor in its interim and annual financial
statements about its obligation under guarantees. This interpretation also
clarifies the requirements related to the recognition of a liability by a
guarantor at the inception of a guarantee for the obligations the guarantor has
undertaken in issuing that guarantee. The initial recognition and measurement
provisions of this statement shall be applied only on a prospective basis to
guarantees issued or modified after December 31, 2002 irrespective of the
guarantors fiscal year-end. The disclosure requirements are effective for
financial statements of interim or annual periods ending after December 31,
2002. We believe that the adoption of this standard will have no impact on its
financial statements.


                                       12
<PAGE>
       In January 2003, the FASB issued FIN No. 46, Consolidation of Variable
Interest Entities." This interpretation of Accounting Research Bulletin No. 51,
Consolidated Financial Statements, addresses consolidation by business
enterprises of variable interest entities. The provisions of this interpretation
are effective immediately for all variable interest entities created after
January 31, 2003; for the first fiscal year or interim period beginning after
June 15, 2003 for variable interest entities in which an enterprise holds a
variable interest that it acquired before February 1, 2003. We believe that the
adoption of this standard will have no impact on its financial statements.

       In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity"
("SFAS 150"). SFAS 150 addresses how an issuer classifies and measures certain
financial instruments with characteristics of both liabilities and equity. SFAS
150 requires that an issuer classify a financial instrument that is within its
scope as a liability (or an asset in some circumstances). SFAS 150 will apply to
financial instruments entered into or modified after May 31, 2003. We believe
that the adoption of this standard will have no impact on its financial
statements.

14.      INVENTORIES:

        Since a majority of our product is imported from Southeast Asia, it is
our practice to maintain a certain level of safety-stock inventory. Inventories
are accounted for on a first-in, first-out ("FIFO") basis and are valued at the
lower of actual cost or market.

15.     KEY CUSTOMERS:

        Our customers include leading foodservice distributors and healthcare
product suppliers. During the three months ended September 30, 2003, AHPC's
national customer accounted for 77.9% of net sales. The loss of this customer
would have a materially adverse effect on us. Our customers tend to limit the
number of qualified vendors they purchase from to gain efficiencies across their
product line. We, therefore, expend substantial efforts to maintain and grow our
relationships with our existing major customers. However, our products are
ultimately distributed by our national customer, through their combined networks
of over 40 operating companies, to thousands of foodservice organizations and
medical facilities throughout the United States. The ultimate end-users of our
products are foodservice organizations and medical facilities, healthcare
professionals and individuals who use our gloves.

16.     CREDIT FACILITY:

        On December 1, 1998, we obtained a domestic three-year credit facility
from GE Capital, a large commercial credit company. This asset based lending
loan and security agreement included a $10,000,000 revolving line of credit with
a $7,000,000 letter of credit sub-facility. On March 31, 1999, we amended our
Loan and Security Agreement by increasing the maximum credit loan limit from
$10,000,000 to $15,000,000 subject to availability, based on a formula using
accounts receivable and inventory. As part of the amendment, the letter of
credit subfacility was increased from $7,000,000 to $11,000,000. The line of
credit borrowings carry an interest rate of commercial paper plus 4.5% (1.06% at
September 30, 2003). At September 30, 2003, we had outstanding $1,280,678 on the
revolving line of credit and $852,634 of letter of credit liabilities under the
credit facility. As of September 30, 2003, we were not in compliance


                                       13
<PAGE>
with certain of our covenants and have obtained waivers of these covenant
violations from the financial institution.

        In conjunction with the waiver of the covenant violations as of June 30,
2003, the existing credit facility agreement was amended to expire on December
31, 2003.

17.       MEDICAL BUSINESS:

        On March 1, 2002, our subsidiary, American Health Products Corp, entered
into a Transition Services Agreement with Maxxim Medical, Inc. (MAXXIM), whereby
MAXXIM agreed to service most of our acute-care medical customers. As a result
of this transition, we have substantially reduced our personnel in our medical
division and have transitioned the business with respect to most of our
customers in the medical division to MAXXIM. As of September 30, 2003, we had an
outstanding account receivable with MAXXIM of $280,115.41 (which included
$250,000 of the fees they agreed to pay us for entering into the agreement).
This amount has been fully reserved due to MAXXIM's bankruptcy filing on
February 11, 2003. We now service our medical customers either direct or
indirect through distributors, other then MAXXIM.

18.     NASDAQ LISTING:

       On February 14, 2002, NASDAQ notified us that the bid price of our common
stock had closed at less than $1.00 per share over the previous 30 consecutive
trading days, and, as a result, did not comply with Marketplace Rule 4310(c)(4)
(the "Rule"). Therefore, in accordance with Marketplace Rule 4310(c)(8)(D), we
were provided 180 calendar days, or until August 13, 2002, to regain compliance
with the Rule.

       On August 14, 2002, NASDAQ notified us that we had not regained
compliance in accordance with Marketplace Rule 4310(c)(8)(D). However, NASDAQ
noted that we meet the initial listing requirements for the NASDAQ SmallCap
Market under Marketplace Rule 4310(c)(2)(A). Specifically, we qualify with the
$5,000,000 stockholders equity requirement. Therefore, in accordance with
Marketplace Rule 4310(c)(8)(D), we were provided an additional 180 days, or
until February 10, 2003, to regain compliance. In order to regain compliance our
common stock was required to close at $1.00 per share or more for a minimum of
ten consecutive trading days. If compliance with this Rule could not be
demonstrated by February 10, 2003, NASDAQ advised that our securities would be
delisted.

        On January 30, 2003, NASDAQ extended its minimum bid price compliance
periods. Specifically, NASDAQ announced it would maintain the initial 180-day,
calendar-day bid price grace period for all SmallCap issuers, but extend the bid
price grace period for SmallCap issuers demonstrating compliance with the core
SmallCap initial listing criteria from 180 to up to 540 days (approximately 12
months). Compliance with this standard is to be verified every 180 days.

       On April 9, 2003, we received notice from NASDAQ that, over the last 30
days, our Common Stock had not maintained a minimum market value of publicly
held shares ("MVPHS") of $1,000,000, as required for continued inclusion by
Marketplace Rule 4310 (c)(7) (the "Rule"). NASDAQ further advised that, in
accordance with Marketplace Rule 4310 (c)(8)(B), we would be provided 90 days,
or until July 8, 2003, to regain compliance. If, at any


                                       14
<PAGE>
time before July 8, 2003, the MVPHS of our Common Stock is $1,000,000 or more
for a minimum of ten consecutive trading days, NASDAQ would provide written
notification that we were in compliance with the rule. If compliance with this
rule was not demonstrated by July 8, 2003, NASDAQ advised it would provide
written notification that our securities would be delisted, subject to the
opportunity to appeal this determination to a listing Qualifications Panel.

       Subsequently, we achieved compliance with the MVPHS requirement but were
still not in compliance with the $1.00 minimum bid price requirement. On July
24, 2003 a hearing was held before the Nasdaq Listing Qualifications Panel. The
result of this hearing was that we received an additional period of time, until
September 30, 2003, to comply with the minimum bid price requirement. On October
23, 2003 we were advised by Nasdaq that since we had demonstrated a plan to
achieve the $1.00 minimum bid price and provided us with an extension based upon
the following terms:

      (1)   On or before November 5, 2003 we must file a proxy statement with
            the SEC and Nasdaq evidencing our intent to seek shareholder
            approval for the implementation of a reverse stock split sufficient
            to satisfy the $1.00 bid price requirement.

      (2)   On or before January 5, 2004 we must evidence a closing bid price of
            at least $1.00 per share and, immediately thereafter, a closing bid
            price of at least $1.00 per share for a minimum of ten consecutive
            trading days.

       On November 5, 2003 we filed a Notice of Special Meeting of Shareholders
with the SEC and Nasdaq. This meeting was called to have the following items
approved:

       To amend our Articles of Incorporation, which will affect the following
items:

            (a)   change our name to AHPC Holdings, Inc.;

            (b)   eliminate our Class A Common Stock, par value $.01 per share,
                  increase the number of authorized shares of Common Stock, par
                  value $.01 per share, from 10,000,000 to 50,000,000 shares and
                  authorize the issuance of up to 2,000,000 shares of preferred
                  stock, par value $.01 per share;

            (c)   reflect a one share for two shares reverse stock split of our
                  outstanding Common Stock, subject to an increase in the amount
                  of this reverse split, if necessary, to result in an
                  adjustment of the closing bid price of our Common Stock, as
                  adjusted for the reverse stock split, to exceed $1.00 per
                  share; and

            (d)   change the minimum number of persons who may comprise our
                  board of directors from five to three.

19.     WEST COAST DOCK STRIKE:

        During October 2002, labor negotiations between the Pacific Maritime
Association and the International Longshore and Warehouse Union broke down
resulting in all West Coast ports being closed for ten days. Since we import all
our products through these ports, we were unable


                                       15
<PAGE>
to have product delivered during this time period. Additionally, by the end of
the tenth day, work stoppage we had 25 containers waiting to be unloaded at
various ports on the West Coast. It took us approximately 60 days to clear this
backlog. Due to the work stoppage and subsequent shipping delays we incurred
additional costs of approximately $297,000.

20.     MAXXIM BANKRUPTCY:

        On February 11, 2003, MAXXIM filed for protection under Chapter 11 of
the Federal Bankruptcy Act in the District of Delaware. It is our understanding
that they plan to continue to do business and to reorganize their operations as
a debtor in possession. Under our Transition Services Agreement dates as of
March 1, 2002, with MAXXIM, MAXXIM agreed to pay us $375,000 in the aggregate
upon achievement of certain milestones, all of which were achieved. To date,
MAXXIM has only paid $125,000 of such obligations; however, we have included as
income the accrued, unpaid portion of these obligations. The total amount due
from MAXXIM is $280,115; of this amount, $250,000 is for payments due under the
transition agreement. This amount has been fully reserved due to MAXXIM's
bankruptcy filing on February 11, 2003.

21.      FORBEARANCE AGREEMENT

        On March 12, 2003 we entered into a forbearance agreement with our
lender, GE Capital Services, whereby they agreed to forbear from exercising its
rights under the loan agreement as a result of events of defaults, which were
continuing at that time. The terms of this agreement required us to maintain
certain financial covenants and to receive payment of at least $2 million of
intercompany debt from WRP Asia (as described elsewhere in this document). This
agreement was scheduled to expire on June 30, 2003; however, we have entered
into an amendment to the forbearance agreement that extends the term through
December 31, 2003. Upon expiration of this agreement, as amended, the lender
will have the right to exercise its rights and remedies immediately, including
but not limited to (i) ceasing to make any further loans to us and (ii) the
acceleration of our obligations to the lender. We are taking aggressive measures
to insure that we have adequate financing in the future; we are in discussions
with several financial institutions about replacing our current credit facility.
We fully expect, but cannot guarantee, that we will be successful in replacing
our existing credit facility, through either our existing lender or a new
lender, prior to December 31, 2003. We are also in discussion with several
potential investors regarding a significant equity investment. We can make no
assurances as to whether any investment proposals will be received and, if so,
to what extent they will be dilutive to existing investors. Due to the nature of
our business, importing product from Asia and the extended time period required
for those purchases to convert to cash, we rely on our credit facility to
finance these purchases.

22.      WRP ASIA FINANCIAL RESTRUCTURING

        On July 8, 2003 WRP Asia announced the completion of its financial
restructuring, which involved restructuring and reducing WRP Asia's debt
position and providing additional new funding. Due to the terms of the
restructuring, WRP Asia was prohibited from repaying certain debt, including our
intercompany debt in the short term. At that time we began exploring other
opportunities to gain compliance with our lender's requirement of a paydown by
WRP Asia of its intercompany debt. On October 6, 2003 we announced the signing
of a non-binding letter of intent with WRP Asia to enter into a stock redemption
and exchange agreement.


                                       16
<PAGE>
        On November 3, 2003 we announced the signing of a definitive stock
redemption and exchange agreement (the "Agreement") with WRP Asia. The Agreement
calls for us to redeem 1,252,538 shares of Class A Common Stock and the
2,500,000 shares of Class B Common Stock, which comprise all of WRP Asia's
holdings. Collectively, these shares represent approximately 53.2% of our
outstanding Capital Stock. The consideration for the redemption is: (i) the
conveyance to WRP Asia of our 70% ownership interest in its subsidiary PT Buana
Multicorpora ("PTB") Indonesia, an Indonesian based manufacturer of gloves; and
(ii) excuse of all indebtedness owing to us or our subsidiaries from WRP Asia
and from PTB with the exception of our obligation to be responsible for trade
payables owing to PTB for recent product purchases. We also announced the
execution of a five-year supply agreement from WRP Asia and PTB to us (through
our subsidiary American Health Products Corporation), calling for the purchase
of a portion of our glove requirements, which equates to the appropriate
annualized quantities that we are currently purchasing from PTB and WRP Asia.
The Board of Directors of both WRP Asia and us have approved the transaction.

        We anticipate that the transaction will close by November 30, 2003. At
that time, based on the current market price for our common stock of $.78 per
share, we anticipate incurring a loss on this transaction of approximately $1.3
million. An increase to our common stock price will reduce this loss and a
considerable appreciation in common stock price would cause us to incur a gain
on the transaction. Likewise, a decline in our common stock price would cause
the loss on the transaction to increase.

23.      SUBSEQUENT EVENT

        On October 16, 2003, we entered into an agreement with the landlord of
our Itasca Warehouse to amend the Lease by extending the term of the Lease by
one year from June 1, 2004 to May 30, 2005.

      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

        Forward-looking statements in this Item 2, Management's Discussion and
Analysis of Financial Condition and Results of Operations, including statements
regarding new products and markets, gross margins, selling, general and
administrative expenses, liquidity and cash need and our plans and strategies,
are all based on current expectations, and we assume no obligation to update
this information. Numerous factors could cause actual results to differ from
those described in the forward-looking statements. We caution investors that our
business is subject to significant risks and uncertainties.

        Our wholly owned subsidiary, American Health Products Corporation
("AHPC"), is engaged in the marketing and distribution of high-quality,
disposable, examination, foodservice and specialty gloves in the United States
and has been in the glove business since our incorporation in January 1989. For
the three months ended September 30, 2003, we recorded net sales of $9,786,226.
Our 70% owned subsidiary, PT WRP Buana Multicorpora ("PT Buana"), which
commenced operations in April 1996, owns and operates an Indonesian glove
manufacturing plant. PT Buana manufactures high-quality, disposable latex exam
and foodservice gloves.


                                       17
<PAGE>
      THREE MONTHS ENDED SEPTEMBER 30, 2003, COMPARED TO THE THREE MONTHS ENDED
SEPTEMBER 30, 2002:

        Our net sales are derived from the sale of finished product, net of
allowable rebates, royalties, discounts and returns. Net sales include glove
sales from AHPC's glove product line and latex exam glove sales from PT Buana,
exclusive of its sales to AHPC. Net sales totaled $9,786,226 and $10,541,504 for
the three months ended September 30, 2003 and 2002, respectively. This
represents a 7.2% decline in net sales for the year compared to the year earlier
period. The decrease in sales of $755,278 was due, in part, to our transition
out of most of our medical business to MAXXIM pursuant to a Transition Service
Agreement.

        Cost of goods sold includes all costs to manufacture, purchase and
obtain the finished product, including costs such as ocean freight, customs,
duty and warehousing. Cost of goods sold decreased 5.6% from $8,526,381 for the
three months ended September 30, 2002, to $8,048,922 for the three months ended
September 30, 2003, due to the decline in sales caused by our transition out of
most of the acute-care medical business. As a percentage of net sales, cost of
goods sold increased from 80.9% for the three months ended September 30, 2002,
to 82.2% for the three months ended September 30, 2003. The gross profit
percentage decreased to 17.8% in the three month ended September 30, 2003,
versus 19.1% in the same period of 2002. The gross profit percentage decrease is
attributed to an increase in the cost of raw latex, which increased by more than
50% versus the comparable 2002 period. We continue to expect our gross margins
to be affected by the price of latex, changes in product mix, competition,
manufacturing capacity levels and other factors.

        Selling expenses include all salaries and payroll related costs for
sales and marketing staff together with other sales related expenses such as
sales commissions, travel costs, trade shows, advertising, promotions and
delivery costs. Selling, general and administrative ("SG&A") expenses increased
by 9.9% from $2,090,328 for the three months ended September 30, 2002, to
$2,297,740 for the three months ended September 30, 2003. The increase of
$207,412 in SG&A expenses is attributable to an increase in manufacturing
operating expenses.

        Loss from operations was $(560,436) for the three months ended September
30, 2003, as compared to loss from operations of $(75,205) for the three months
ended September 30, 2002. This loss from operations reflects the reduction in
sales and increased costs of goods sold.

        Interest expense declined during the three months ended September 30,
2003, to $44,020 compared to $48,725 in the same quarter of 2002. This decrease
is attributable to debt reductions on our line of credit and lower interest
rates during the quarter in 2003 versus the 2002 comparable quarter.

        We recorded a foreign currency exchange loss of $7,733 in the quarter
ended September 30, 2003 versus a foreign exchange gain of $7,188 in the
comparable period in 2002 from our Indonesian subsidiary, PT Buana. As currency
exchange rates fluctuate and depending upon the mix of assets and liabilities in
PT Buana's books in Indonesian rupiah, an exchange gain or loss


                                       18
<PAGE>
will be incurred. These foreign currency exchange gains or losses are reported
as a component of the SG&A expense category in the consolidated statements of
operations. PT Buana uses the U.S. dollar as its functional currency. PT Buana
continues to be exposed to foreign currency exchange rate fluctuations and may
incur exchange gains or losses in the future. Indonesia continues to experience
economic and political instability, which is characterized by fluctuations in
its foreign currency exchange rate, interest rates, stock market and inflation
rate. The financial statements do not include any adjustment that might result
from these uncertainties and any related effects will be reported in the
financial statements as they become known and estimable.

          Other income for the quarter ended September 30, 2003 and 2002, was
$29,479 and $284,149, respectively. The decrease was due to the proceeds from
the Transition Services Agreement with MAXXIM in the three months ended
September 30, 2003.

        The benefit for income taxes for the three months ended September 30,
2003, was $50,748 and $(4,255) for the comparable 2002 period. Our U.S.
operations generated net operating loss carry-forwards ("NOL's") in prior years
of which approximately $2.3 million is remaining from June 30, 2003. These NOL's
are fully reserved and are included as a component of deferred tax assets.

        For the three months ended September 30, 2003, our net loss was
$(616,199), compared to a net income of $125,422 in the same period of 2002.
Diluted (loss) income per share for the three months ended September 30, 2003
and 2002, was $(.09) and $.02, respectively.

LIQUIDITY AND CAPITAL RESOURCES:

THREE MONTHS ENDED SEPTEMBER 30, 2003:

        Cash and cash equivalents at September 30, 2003 was $531,921, an
increase of $111,002 from $420,919 at June 30, 2003. We experienced an increase
in cash flows during the three months ended September 30, 2003, primarily from
cash provided by operating activities.

        Our operations provided cash of $556,685 during the three months ended
September 30, 2003, primarily as a result of a tax refunds received of $526,000
for 2002 amended returns.

        Net trade accounts receivable at September 30, 2003 decreased 11.7% to
$2,045,625 from $2,317,178 at June 30, 2003. The decrease in accounts receivable
was due to the loss of the Walgreens business. Net inventories at September 30,
2003 were $8,662,616, a decrease from the level at June 30, 2003, of $8,796,339,
due to reduction of safety stock levels.

        During the three months ended September 30, 2003, we used cash in
investing activities of $282,805. We spent $189,279 for capital improvement
expenditures during the three-month period primarily at PT Buana, our Indonesian
manufacturing plant. These expenditures included equipment purchases and
upgrades to expand our capacity to manufacture higher-margin products, including
powder-free latex gloves.

        During the three months ended September 30, 2003, cash was used from
financing activities in the amount of $162,908. We decreased borrowings on our
line of credit facility by $173,430.


                                       19
<PAGE>
        The outstanding accounts receivable from WRP Asia results primarily from
sales of product to WRP Asia (powder-free exam gloves produced by PT Buana),
cash advances, charges for obtaining FDA approval of the gloves imported from
WRP Asia and other items. AHPC purchased virtually all of its latex powder-free
exam gloves from WRP Asia in 2002, 2001, 2000 and 1999. Management believes
transactions between operating segments are made at prevailing rates. AHPC
purchases its powdered latex gloves from its 70% subsidiary, PT Buana, as well
as from third-party suppliers other than WRP Asia.

        As of September 30, 2003, we have outstanding accounts receivable from
WRP Asia of approximately $9,287,712. Subsequent to June 30, 2002, the amounts
due to PT Buana of approximately $5,586,000 were assigned to us in partial
satisfaction of intercompany amounts due from PT Buana to us. As of September
30, 2003, there are approximately $345,272 owing PT Buana from WRP Asia.

        As of September 30, 2003, we have accounts payable to WRP Asia of
approximately $3,890,537, primarily resulting from the purchase of inventories
from WRP Asia.

        The net amount due from WRP Asia, before allowance for doubtful accounts
at September 30, 2003, was approximately $5,397,175, against which we have
provided an allowance for doubtful accounts of approximately $5,586,000
(representing all amounts due for the sale of product from PT Buana to WRP Asia
at September 30, 2003).

        Subsequent to June 30, 2002, we entered into a formal agreement with WRP
Asia to provide for the full and complete right of offset of any trade payables
due against amounts they owe to us and AHPC. We continue to purchase gloves from
WRP Asia and believe that the unreserved amounts due to WRP Asia from AHPC of
approximately $565,142 at March 31, 2003 are realizable based upon the agreement
granting right of offset and ongoing purchases from WRP Asia. In management's
opinion, while we have been advised by WRP Asia that it does not currently
intend to seek protection from creditors, should such action take place, we
would have to reevaluate the ability to offset payables to WRP Asia against our
receivables from them.

        On September 18, 2002, our Board of Directors passed a resolution that
limits the net intercompany amount due from WRP Asia exceeding the balance of
$6,200,000 on a consolidated basis. In the event that WRP Asia desires to
purchase product from PT Buana, and the effect of this sale would be to increase
the net amount due beyond $6,200,000, the resolution requires WRP Asia to
support these purchases by payment of cash in advance or tender of an
irrevocable letter of credit to PT Buana to cover the purchase price of the
order to the extent such amount exceed $6,200,000.

        On July 24, 2002, our Board of Directors approved a proposal submitted
by the independent directors to form a Special Evaluation Committee (the
"Committee"). The Committee is comprised of our "B" Directors, Robert J. Simmons
and Don L. Arnwine as well the independent "A" Directors, G. Jeff Mennen and
Richard J. Swanson. The purpose of the Committee is to examine the WRP Asia
restructuring process as well as the options and alternatives available to us,
which include the negotiation and possible closing of the stock redemption
agreement with WRP Asia presently in effect.


                                       20
<PAGE>
        On December 1, 1998, we obtained a domestic three-year credit facility
from GE Capital, a large commercial credit company. This asset based lending
loan and security agreement included a $10,000,000 revolving line of credit with
a $7,000,000 letter of credit sub-facility. On March 31, 1999, we amended our
Loan and Security Agreement by increasing the maximum credit loan limit from
$10,000,000 to $15,000,000 subject to availability, based on a formula using
accounts receivable and inventory. As part of the amendment, the letter of
credit subfacility was increased from $7,000,000 to $11,000,000. The line of
credit borrowings carry an interest rate of commercial paper plus 4.5% (1.06% at
September 30, 2003). At September 30, 2003, we had outstanding $1,280,678 on the
revolving line of credit and $852,634 of letter of credit liabilities under the
credit facility. As of September 30, 2003, we were not in compliance with all of
our covenants and have obtained waivers of these covenant violations from the
financial institution.

         We currently expect to have cash needs during the next year and beyond
for funding the growth of the existing glove business, launch and promotion of
our SafePrep foodservice business and for other uses. These cash needs may arise
in connection with various events such as for: (i) the expansion into new
products; (ii) the expansion into new markets; (iii) funding the promotion of
our branded products; (iv) repayment of debt obligations; (v) purchasing our
Common Stock in connection with our stock repurchase program; and (vi)
manufacturing capital improvements. We believe that our cash and cash to be
generated from future operations plus our credit facility will be sufficient to
fund our ongoing operations.

        As of September 30, 2003, we had the following contractual obligations
and commercial commitments:

<TABLE>
<CAPTION>
                                                    PAYMENTS DUE BY PERIOD
                                                    ----------------------
       CONTRACTUAL
       OBLIGATION          TOTAL           LESS THAN 1 YEAR  1-3 YEARS  4-5 YEARS
       ----------          -----           ----------------  ---------  ---------

<S>                       <C>              <C>               <C>        <C>
   Operating Leases       $1,052,645           $ 533,011      $519,634     -0-
</TABLE>


        Operating leases primarily represent our leases for our corporate office
and warehouse facilities. The letters of credit are issued under our credit
facility and are commercial obligations related to product purchases. Insurance
premium financing was used to finance our product liability insurance.
Short-term borrowings represent borrowings under our credit facility primarily
to finance working capital.


                                       21
<PAGE>
        ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

        We are exposed to the impact of interest rate changes, foreign currency
fluctuations and changes in the market value of investments. We have not entered
into interest rate caps or collars or other hedging instruments.

        Exposure to changes in interest rates is limited to borrowings under
revolving credit and debt agreements, which have variable interest rates, tied
to the prime and commercial paper rates. We estimate that the fair value of each
debt instrument approximated its market value at September 30, 2003.

        We are subject to fluctuations in the value of the Indonesian rupiah
vis-a-vis the U.S. dollar. The investment in the Indonesian subsidiary is
remeasured into the U.S. dollar and the book value of the assets and liabilities
of this operation at September 30, 2003, approximated its fair value.

        ITEM 4.  CONTROLS AND PROCEDURES

        Our Chief Executive Officer and Chief Financial Officer have concluded,
based on their evaluation within 90 days of the filing date of this report, that
our disclosure controls and procedures are effective for gathering, analyzing
and disclosing the information we are required to disclose in our reports filed
under the Securities Exchange Act of 1934. There have been no significant
changes in our internal controls or in other factors that could significantly
affect these controls subsequent to the date of the previously mentioned
evaluation.

        We maintain a system of controls and procedures designed to provide
reasonable assurance as to the reliability of the financial statements and other
disclosures included in this report, as well as to safeguard assets from
unauthorized use or disposition. However, no cost effective internal control
system will preclude all errors and irregularities, and management is
necessarily required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures.

        We evaluated the effectiveness of the design and operation of our
disclosure controls and procedures under the supervision and with the
participation of management, including our chief executive officer and chief
financial officer, within 90 days prior to the filing date of the report. Based
upon that evaluation, our chief executive officer and chief financial officer
concluded that our disclosure controls and procedures are effective in timely
alerting them to material information required to be included in our periodic
Securities and Exchange Commission filings. No significant changes were made to
our internal controls or other factors that could significantly affect these
controls subsequent to the date of their evaluation.


                                       22
<PAGE>
                                     PART II

ITEM 1-5.

No changes

ITEM 6 (A)  EXHIBIT 99.1

      31.1  Certification of CEO pursuant to Section 302 of the Sarbanes-Oxley
            Act of 2002.

      31.2  Certification of CFO pursuant to Section 302 of the Sarbanes-Oxley
            Act of 2002.

      32.1  Certification of CEO and CFO pursuant to Section 906 of the
            Sarbanes-Oxley Act of 2002.

        (B) REPORTS ON FORM 8-K

      During the three-month period ended September 30, 2003, we did not file
      any reports on Form 8-K.

SIGNATURES

            Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.




                                                    WRP Corporation
                                                    (Registrant)


Date:   November 14, 2003                         By:/s/ Alan E. Zeffer
                                                     ------------------
                                                  Name:  Alan E. Zeffer
                                                  Title: Chief Financial Officer


                                       23